A PHASE 1 TRIAL OF D2C7-IT IN COMBINATION WITH ATEZOLIZUMAB IN RECURRENT WHO GRADE IV MALIGNANT GLIOMA (MG)
conference contribution
posted on 2020-11-01, 00:00authored byAnnick Desjardins, Dina Randazzo, Vidya Chandramohan, Katherine Peters, Margaret Johnson, Daniel Landi, Mustafa Khasraw, Stevie Threatt, Chevelle Bullock, James Herndon, Eric Lipp, John Sampson, Allan Friedman, Henry Friedman, David Ashley, Darell Bigner
A PHASE 1 TRIAL OF D2C7-IT IN COMBINATION WITH ATEZOLIZUMAB IN RECURRENT WHO GRADE IV MALIGNANT GLIOMA (MG)